Travere reports Q3 2026 results, FILSPARI sales climb as pipeline advancesNov 2Quarterly updatepegtibatinasesparsentan
Ligand raises EPS guidance floor, closes XOMA Royalty deal, reports pipeline progressAug 6Quarterly updateLigand Pharmaceuticals Inc
Travere reports Q2 2026 results as FSGS launch begins and civorebrutinib deal closesAug 4Quarterly updatepegtibatinasesparsentan